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CASE REPORT
Disseminated lung cancer presenting as a rectal mass
Mia M. Noergaard1, Inger M. H. Stamp2 and Uffe Bodtger1,3*
1Department of Pulmonology, Naestved Hospital, Naestved, Denmark; 2Department of Pathology, Naestved
Sygehus, Naestved, Denmark; 3Institute of Regional Health Research, University of Southern Denmark,
Odense, Denmark
Primary lung cancer is the leading cause of cancer-related deaths globally, and approximately 50% had
metastatic disease at the time of diagnosis. A rectal mass and unintended weight loss are common
manifestations of rectal cancer. Our case presented with a rectal mass, but workup revealed a metastatic lesion
from lung cancer. Lung cancer metastases to the lower gastrointestinal tract imply reduced survival compared
with the already poor mean survival of stage IV lung cancer. Despite relevant therapy, the patient died
5 months after referral.
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P
rimary lung cancer is the leading cause of cancer-
related deaths globally. Metastatic disease at diag-
nosis is very common, typically involving liver,
brain, adrenals, and bones. Symptomatic intestinal/colo-
nic metastases affect 0.20.5% (5% in autopsy studies)
but imply a median survival of 3 months compared with
8 months in overall stage IV non-small cell lung cancer
(1, 2). This case presented with a rectal mass, a common
clinical manifestation of another common malignancy,
colorectal cancer. The case illustrates the unpredictability
of malignant spread, and the occasional mismatch between
clinical presentation and tissue sampling results.
Case presentation
A 70-year-old male never-smoker experienced an 8-kg
weight loss during 6 months, alternating diarrhoea/
obstipation without bloody stools, slight coughing, and
dyspnoea. He had a history of hypertension for many
years, uncomplicated and treated with losartan/thiazide
50/12.5 mg and amlodipine 10 mg once daily. Nine years
earlier, he was diagnosed with a transitiocellular, papil-
lary bladder tumour, grade III with invasion; underwent
successful endoscopic resection without need for oncolo-
gical treatment; and was followed with annual cystoscopy.
Three years later, he was surgically treated for a relapse of
transitiocellular, papillary bladder tumour (grade I) and
was followed for an additional 5 years without signs of
recurrent disease at annual cystoscopy.
He was a retired industrial worker but with no known
occupational exposure to asbestosis, silica, or dust. He
was living with his spouse and had no hobbies resulting in
exposure to hazardous fumes or dusts.
Diagnostic workup
He was referred to an outpatient colonoscopy (17 months
after he ended urological control visits), revealing an
obstructing lower rectal mass. Only a paediatric coloscope
could pass the lesion, and biopsies revealed adenocarci-
noma, immunohistochemical (IHC) analyses positive for
CK7 and TTF-1 (Fig. 1), and negative for GATA, CK20,
CDX2, PLAP, CD117, PSA, and S100P. PCR showed
wild-type EGFR status. Direct histological comparison
showed no resemblance with his urological cancer.
Thoracoabdominal contrast-enhanced PET-CT scan
showed multiple, PET-positive, enlarged mediastinal and
retroperitoneal lymph nodes, a right-sided pleural effu-
sion and associated ipsilateral compression lower lobe
atelectasis, ascites, and a tumour located in the rectum
with invasion to levator muscles and vesicula seminalis
(Figs. 2 and 3). Cytological sampling from mediastinal
lymph nodes and pleural exudate showed identical
adenocarcinoma including IHC profile cells with a high
proliferation index assessed by Ki-67. A bronchoscopy
showed no visual tumour.
At a multidisciplinary team conference, it was decided
that the final diagnosis was primary lung cancer, stage
TxN3M1b with local metastases to mediastinal lymph
nodes, pleura, rectum, and peritoneum. The IHC results
were considered to rule out primary colorectal cancer or
vesical cancer with thoracic dissemination.
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He started palliative carboplatin/vinorelbine and avas-
tin (43 days after referral to gastroenterologist) as 4 series
with 3 weeks intervals. Three-month PET-CT showed a
mixed response with an overall sign of progression, and
second-line chemotherapy was planned. Before onset, he
was admitted with acute dyspnoea and died 2 days later.
Discussion
The current case describes a rare site of primary lung
cancer metastasis with fatal outcome 153 days after
referral. Despite an unusual presentation, neither diag-
nosis nor therapy onset was delayed.
One can question the validity of the diagnosis as the
patient was a never-smoker without evident lung lesions.
However, as three key IHC markers for colorectal cancer
were negative, positive CK7 and TTF-1, and no upper
G-I CT/PET lesions, neither a primary upper or lower
G-I cancer seems likely (3). We found three published
case reports on rectal metastases from lung cancer: two
were late metastases in earlier surgically resected patients
(4, 5), and a recently published case on metastatic, poorly
differentiated squamous cell lung carcinoma with multiple
metastases to liver, skin, bone, and muscle (6).
It is unresolved if intestinal spread reflects a more
aggressive or more advanced disease. G-I metastasis may
occur through haematogenic spread via the mesenteric
inferior artery supplying descending colon, sigmoideum
and superior part of rectum (7, 8). Yet, cancer metastasis
is complex, involving coordination of expression/suppres-
sion of numerous genes, and is not fully understood. IL-8
overexpression may contribute to a more aggressive
phenotype yet our case was negative for CK20, the IL-8
receptor (9).
Fig. 1. Immunohistochemical staining of histological biopsy from rectal mass: an adenocarcinoma positive for TTF-1 (A) and
CK7 (B).
Fig. 2. Chest PET-CT scan showing no sign of a primary
lung lesion but multiple enlarged lymph nodes, a left-sided
compression atelectasis, and ipsilateral pleural effusion.
Fig. 3. Abdominal PET-CT scan showing a rectal mass,
moderate quantities of ascites, and enlarged lymph nodes in
pelvis and groin.
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Improved survival after intestinal single-metastasis
resection has been demonstrated in carefully selected
patients, but for most patients with intestinal metastases,
palliation remains the only available therapy (10).
An improved understanding of the pathobiological
mechanisms involved in cancer metastases is needed to
elucidate targets for improved therapy.
Conflict of interest and funding
The authors have not received any funding or benefits
from industry or elsewhere to conduct this study.
References
1. Mehta RS, Liman AD, Passero VA, Liman AK. Lung cancer
with gastrointestinal metastasis  review of theories of metas-
tasis with three rare case descriptions. Cancer Microenviron.
2013; 6: 20311. doi: http://dx.doi.org/10.1007/s12307-013-
0135-1
2. Kim MS, Kook EH, Ahn SH, Jeon SY, Yoon JH, Han MS, et al.
Gastrointestinal metastasis of lung cancer with special emphasis
on a long-term survivor after operation. J Cancer Res Clin
Oncol. 2009; 135: 297301. doi: http://dx.doi.org/10.1007/
s00432-008-0424-0
3. Miura K, Ishida K, Fujibuchi W, Ito A, Niikura H, Ogawa H,
et al. Differentiating rectal carcinoma by an immunohistological
analysis of carcinomas of pelvic organs based on the NCBI
Literature Survey and the Human Protein Atlas database. Surg
Today. 2012; 42: 51525. doi: http://dx.doi.org/10.1007/s00595-
012-0167-z
4. Miyazu K, Kobayashi K. Rectal metastasis from lung cancer;
report of a case. Kyobu Geka. 2012; 65: 1657.
5. Martinez GE, Coursey CA, Dodd L, Martinez S. Simultaneous
thigh muscle metastasis from lung cancer and Escherichia coli
gas producing myonecrosis. Skeletal Radiol. 2008; 37: 7636.
doi: http://dx.doi.org/10.1007/s00256-008-0489-5
6. Win AZ, Aparici CM. A case of metastatic rectal squamous cell
carcinoma initially diagnosed as lung cancer. J Clin Imaging Sci.
2015; 5: 22. doi: http://dx.doi.org/10.4103/2156-7514.156125
7. Kabwa L, Mattei JP, Noe¨l JP. Intestinal metastases of bronch-
opulmonary cancer. Apropos of a case. J Chir (Paris) 1996; 133:
2903.
8. Pezzuto A, Mariotta S, Fioretti F, Uccini S. Metastasis to the
colon from lung cancer presenting with severe hyponatremia
and dyspnea in a young male: a case report and review of the
literature. Oncol Lett. 2013; 5: 147780.
9. Sunaga N, Imai H, Shimizu K, Shames DS, Kakegawa S,
Girard L, et al. Oncogenic KRAS-induced interleukin-8 over-
expression promotes cell growth and migration and contributes
to aggressive phenotypes of non-small cell lung cancer. Int J
Cancer. 2012; 130: 173344. doi: http://dx.doi.org/10.1002/ijc.
26164
10. Fujiwara A, Okami J, Tokunaga T, Maeda J, Higashiyama M,
Kodama K. Surgical treatment for gastrointestinal metastasis
of non-small-cell lung cancer after pulmonary resection. Gen
Thorac Cardiovasc Surg. 2011; 59: 74852. doi: http://dx.doi.
org/10.1007/s11748-011-0811-3
NSCLC rectal metastasis
Citation: European Clinical Respiratory Journal 2016, 3: 31726 - http://dx.doi.org/10.3402/ecrj.v3.31726 3
(page number not for citation purpose)
